特発性高血圧症（Idiopathic (Essential) Hypertension）：治療薬のグローバル治験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables4
List of Figures 5
Introduction 6
Idiopathic (Essential) Hypertension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Idiopathic (Essential) Hypertension to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Idiopathic (Essential) Hypertension to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Idiopathic (Essential) Hypertension 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Idiopathic (Essential) Hypertension Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43
Takeda Pharmaceutical Company Limited 46
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 46
Daiichi Sankyo Company, Limited 48
Clinical Trial Overview of Daiichi Sankyo Company, Limited 48
Merck & Co., Inc. 50
Clinical Trial Overview of Merck & Co., Inc. 50
Medionics International Inc 52
Clinical Trial Overview of Medionics International Inc 52
Bayer AG 54
Clinical Trial Overview of Bayer AG 54
GlaxoSmithKline plc 56
Clinical Trial Overview of GlaxoSmithKline plc 56
Pfizer Inc. 57
Clinical Trial Overview of Pfizer Inc. 57
Les Laboratoires Servier SAS 58
Clinical Trial Overview of Les Laboratoires Servier SAS 58
Clinical Trial Overview of Top Institutes / Government 59
Institut de Recherches Internationales Servier 59
Clinical Trial Overview of Institut de Recherches Internationales Servier 59
Regional Hospital Holstebro 61
Clinical Trial Overview of Regional Hospital Holstebro 61
National Heart, Lung, and Blood Institute 62
Clinical Trial Overview of National Heart, Lung, and Blood Institute 62
University of Erlangen-Nurnberg 63
Clinical Trial Overview of University of Erlangen-Nurnberg 63
University of Pavia 64
Clinical Trial Overview of University of Pavia 64
St. George’s University of London 65
Clinical Trial Overview of St. George’s University of London 65
Central South University 66
Clinical Trial Overview of Central South University 66
Ehime University Graduate School of Medicine 67
Clinical Trial Overview of Ehime University Graduate School of Medicine 67
Komono Kosei Hospital 68
Clinical Trial Overview of Komono Kosei Hospital 68
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 69
Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 69
Five Key Clinical Profiles 70
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 113